本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

BioCryst製藥

8.91
+0.14501.66%
成交量:16.83萬
成交額:148.66萬
市值:18.63億
市盈率:-34.32
高:8.91
開:8.78
低:8.75
收:8.76
資料載入中...
2021/03/01

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/25

重要事件披露

8-K - Current report
2021/02/25

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/05

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/03

重要事件披露

8-K - Current report
2021/01/29

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/25

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/22

重要事件披露

8-K - Current report
2020/12/22

重要事件披露

8-K - Current report
2020/12/22

重要事件披露

8-K - Current report
2020/12/21

重要事件披露

8-K - Current report
2020/12/17

重要事件披露

8-K - Current report
2020/12/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/07

重要事件披露

8-K - Current report